Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Seminars in Immunopathology
Published in: Seminars in Immunopathology 3/2014

01-05-2014 | Review

The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved

Authors: Ole Petter Rekvig, Johan Van der Vlag

Published in: Seminars in Immunopathology | Issue 3/2014

Login to get access

Abstract

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with various clinical manifestations affecting different tissues. A characteristic feature of SLE is the presence of autoantibodies against double-stranded (ds)DNA, histones and nucleosomes, and other chromatin components. SLE is a prototype type III hypersensitivity reaction. Local deposition of anti-nuclear antibodies in complex with released chromatin induces serious inflammatory conditions by activation of the complement system. The severe renal manifestation, lupus nephritis, is classified based on histological findings in renal biopsies. Apoptotic debris, including chromatin, is present in the extracellular matrix and circulation of patients with SLE. This may be due to an aberrant process of apoptosis and/or insufficient clearance of apoptotic cells/chromatin. The non-cleared apoptotic debris may lead to activation of both the innate and adaptive immune systems. In addition, an aberrant presentation of peptides by antigen-presenting cells, disturbed selection processes for lymphocytes, and deregulated lymphocyte responses may be involved in the development of autoimmunity. In the present review, we briefly will summarize current knowledge on the pathogenesis of SLE. We will also critically discuss and challenge central issues that need to be addressed in order to fully understand the pathogenic mechanisms involved in the development of SLE and in order to have an improved diagnosis for SLE. Disappointingly, in our opinion, there are still more questions than answers for the pathogenesis, diagnosis, and treatment of SLE.
Literature
1.
Amital H, Heilweil M, Ulmansky R et al (2005) Treatment with a laminin-derived peptide suppresses lupus nephritis. J Immunol 175:5516–5523PubMed
2.
Andrzejewski C Jr, Rauch J, Lafer E et al (1981) Antigen-binding diversity and idiotypic cross-reactions among hybridoma autoantibodies to DNA. J Immunol 126:226–231PubMed
3.
Arbuckle MR, Mcclain MT, Rubertone MV et al (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349:1526–1533PubMed
4.
5.
Ardoin SP, Pisetsky DS (2008) The role of cell death in the pathogenesis of autoimmune disease: HMGB1 and microparticles as intercellular mediators of inflammation. Mod Rheumatol 18:319–326PubMedCentralPubMed
6.
Ash Lerner A, Ginsberg Strauss M, Pewzner Jung Y et al (1997) Expression of an anti-DNA-associated VH gene in immunized and autoimmune mice. J Immunol 159:1508–1519PubMed
7.
Basnakian AG, Apostolov EO, Yin X et al (2005) Cisplatin nephrotoxicity is mediated by deoxyribonuclease I. J Am Soc Nephrol 16:697–702PubMed
8.
Berden JH (2003) Lupus nephritis: consequence of disturbed removal of apoptotic cells? Neth J Med 61:233–238PubMed
9.
Berden JH, Licht R, Van Bruggen MC et al (1999) Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis. Curr Opin Nephrol Hypertens 8:299–306PubMed
10.
Boackle SA, Holers VM, Chen X et al (2001) Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein. Immunity 15:775–785PubMed
11.
Bolland S, Yim YS, Tus K et al (2002) Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(−/−) mice. J Exp Med 195:1167–1174PubMedCentralPubMed
12.
Boule MW, Broughton C, Mackay F et al (2004) Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med 199:1631–1640PubMedCentralPubMed
13.
Bouts YM, Wolthuis DFGJ, Dirkx MFM et al (2012) Apoptosis and NET formation in the pathogenesis of SLE. Autoimmunity 45:597–601PubMed
14.
Brigido MM, Stollar BD (1991) Two induced anti-Z-DNA monoclonal antibodies use VH gene segments related to those of anti-DNA autoantibodies. J Immunol 146:2005–2009PubMed
15.
Carroll P, Stafford D, Schwartz RS et al (1985) Murine monoclonal anti-DNA autoantibodies bind to endogenous bacteria. J Immunol 135:1086–1090PubMed
16.
Casciola-Rosen L, Andrade F, Ulanet D et al (1999) Cleavage by granzyme B is strongly predictive of autoantigen status: Implications for initiation of autoimmunity. J Exp Med 190:815–825PubMedCentralPubMed
17.
Casciolarosen LA, Anhalt G, Rosen A (1994) Autoantigens targeted in systemic lupus-erythematosus are clustered in 2 populations of surface-structures on apoptotic keratinocytes. J Exp Med 179:1317–1330
18.
Choi J, Kim ST, Craft J (2012) The pathogenesis of systemic lupus erythematosus—an update. Curr Opin Immunol 24:651–657PubMedCentralPubMed
19.
Dang H, Harbeck RJ (1982) A comparison of anti-DNA antibodies from serum and kidney eluates of NZB x NZW F1 mice. J Clin Lab Immunol 9:139–145PubMed
20.
Davies JM (1997) Molecular mimicry: can epitope mimicry induce autoimmune disease? Immunol Cell Biol 75:113–126PubMed
21.
Deocharan B, Qing X, Lichauco J et al (2002) Alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies. J Immunol 168:3072–3078PubMed
22.
Desai DD, Krishnan MR, Swindle JT et al (1993) Antigen-specific induction of antibodies against native mammalian DNA in nonautoimmune mice. J Immunol 151:1614–1626PubMed
23.
Diamond B, Volpe BT (2012) A model for lupus brain disease. Immunol Rev 248:56–67PubMed
24.
Dieker JW, Fransen JH, Van Bavel CC et al (2007) Apoptosis-induced acetylation of histones is pathogenic in systemic lupus erythematosus. Arthritis Rheum 56:1921–1933PubMed
25.
Dieker JW, Van der Vlag J, Berden JH (2004) Deranged removal of apoptotic cells: its role in the genesis of lupus. Nephrol Dial Transplant 19:282–285PubMed
26.
Dieker JW, Van der Vlag J, Berden JH (2002) Triggers for anti-chromatin autoantibody production in SLE. Lupus 11:856–864PubMed
27.
Doyle HA, Mamula MJ (2005) Posttranslational modifications of self-antigens. Ann N Y Acad Sci 1050:1–9PubMed
28.
Ehrenstein MR, Katz DR, Griffiths MH et al (1995) Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice. Kidney Int 48:705–711PubMed
29.
Fairhurst AM, Hwang SH, Wang A et al (2008) Yaa autoimmune phenotypes are conferred by overexpression of TLR7. Eur J Immunol 38:1971–1978PubMedCentralPubMed
30.
Fenton K, Fismen S, Hedberg A et al (2009) Anti-dsDNA antibodies promote initiation, and acquired loss of renal Dnase1 promotes progression of lupus nephritis in autoimmune (NZBxNZW)F1 mice. PLoS One 4:e8474PubMedCentralPubMed
31.
Fenton KA, Tommeras B, Marion TN et al (2010) Pure anti-dsDNA mAbs need chromatin structures to promote glomerular mesangial deposits in BALB/c mice. Autoimmunity 43:179–188PubMed
32.
Fismen S, Hedberg A, Fenton K et al (2009) Circulating chromatin-anti-chromatin antibody complexes bind with high affinity to dermo-epidermal structures in murine and human lupus nephritis. Lupus 18:597–607
33.
Fismen S, Thiyagarajan D, Seredkina N et al. (2013) Impact of the tumor necrosis factor receptor-associated protein 1 (Trap1) on renal DNaseI shutdown and on progression of murine and human lupus nephritis. Am J Pathol 182:688--700
34.
35.
Fransen JH, Hilbrands LB, Jacobs CW et al (2009) Both early and late apoptotic blebs are taken up by DC and induce IL-6 production. Autoimmunity 42:325–327PubMed
36.
Fransen JH, Hilbrands LB, Ruben J et al (2009) Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17. Arthritis Rheum 60:2304–2313PubMed
37.
Fransen JH, Hilbrands LB, Koeter CM, Berden JH, Van der Vlag J. (2009) The role of apoptosis and removal of apoptotic cells in the genesis of systemic lupus erythematosus. Arch Med Sci 5:S466-S477
38.
Gaipl US, Sheriff A, Franz S et al (2006) Inefficient clearance of dying cells and autoreactivity. Curr Top Microbiol Immunol 305:161–176PubMed
39.
Garcia-Romo GS, Caielli S, Vega B et al (2011) Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 3:73ra20PubMedCentralPubMed
40.
Garrett-Sinha LA, John S, Gaffen SL (2008) IL-17 and the Th17 lineage in systemic lupus erythematosus. Curr Opin Rheumatol 20:519–525PubMed
41.
Gilkeson GS, Grudier JP, Karounos DG et al (1989) Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA. J Immunol 142:1482–1486PubMed
42.
Gilkeson GS, Ruiz P, Howell D et al (1993) Induction of immune-mediated glomerulonephritis in normal mice immunized with bacterial DNA. Clin Immunol Immunopathol 68:283–292PubMed
43.
Green MC, Shultz LD (1975) Motheaten, an immunodeficient mutant of the mouse. I. Genetics and pathology. J Hered 66:250–258PubMed
44.
Griffith J, Bleyman M, Rauch CA et al (1986) Visualization of the bent helix in kinetoplast DNA by electron microscopy. Cell 46:717–724PubMed
45.
Grootscholten C, Van Bruggen MC, Van Der Pijl JW et al (2003) Deposition of nucleosomal antigens (histones and DNA) in the epidermal basement membrane in human lupus nephritis. Arthritis Rheum 48:1355–1362PubMed
46.
Guerra SG, Vyse TJ, Cunninghame Graham DS (2012) The genetics of lupus: a functional perspective. Arthritis Res Ther 14:211PubMedCentralPubMed
47.
48.
Haugbro K, Nossent JC, Winkler T et al (2004) Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity. Ann Rheum Dis 63:386–394PubMedCentralPubMed
49.
Hedberg A, Fismen S, Fenton KA et al (2011) Heparin exerts a dual effect on murine lupus nephritis by enhancing enzymatic chromatin degradation and preventing chromatin binding in glomerular membranes. Arthritis Rheum 63:1065–1075PubMed
50.
Hedberg A, Mortensen ES, Rekvig OP (2011) Chromatin as a target antigen in human and murine lupus nephritis. Arthritis Res Ther 13:214PubMedCentralPubMed
51.
Herrmann M, Voll RE, Zoller OM et al (1998) Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 41:1241–1250PubMed
52.
Hobson DJ, Wei W, Steinmetz LM et al (2012) RNA polymerase II collision interrupts convergent transcription. Mol Cell 48:365–374PubMedCentralPubMed
53.
Huerta PT, Kowal C, Degiorgio LA et al (2006) Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci U S A 103:678–683PubMedCentralPubMed
54.
Isenberg D, Lesavre P (2007) Lupus nephritis: assessing the evidence, considering the future. Lupus 16:210–211PubMed
55.
Isenberg DA, Ehrenstein MR, Longhurst C et al (1994) The origin, sequence, structure, and consequences of developing anti-DNA antibodies. A human perspective. Arthritis Rheum 37:169–180PubMed
56.
Isenberg DA, Manson JJ, Ehrenstein MR et al (2007) Fifty years of anti-ds DNA antibodies: are we approaching journey's end? Rheumatology (Oxford) 46:1052–1056
57.
Izui S (1990) Autoimmune accelerating genes, lpr and Yaa, in murine systemic lupus erythematosus. Autoimmunity 6:113–129PubMed
58.
Izui S, Kelley VE, Masuda K et al (1984) Induction of various autoantibodies by mutant gene lpr in several strains of mice. J Immunol 133:227–233PubMed
59.
Jang YJ, Stollar BD (2003) Anti-DNA antibodies: aspects of structure and pathogenicity. Cell Mol Life Sci 60:309–320PubMed
60.
Balow JE, Boumpas DT, Ausin HA (1999) Systemic lupus erythematosus and the kidney. In: Lahiota RG (ed) Systemic lupus erythematosus, 3rd edn. Academic, San Diego, pp 657–685
61.
Kalaaji M, Fenton KA, Mortensen ES et al (2007) Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis. Kidney Int 71:664–672PubMed
62.
Kalaaji M, Mortensen E, Jorgensen L et al (2006) Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells. Am J Pathol 168:1779–1792PubMedCentralPubMed
63.
Kalaaji M, Sturfelt G, Mjelle JE et al (2006) Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis. Arthritis Rheum 54:914–926PubMed
64.
Kalsi JK, Martin AC, Hirabayashi Y et al (1996) Functional and modelling studies of the binding of human monoclonal anti-DNA antibodies to DNA. Mol Immunol 33:471–483PubMed
65.
66.
Krishnan MR, Wang C, Marion TN (2012) Anti-DNA autoantibodies initiate experimental lupus nephritis by binding directly to the glomerular basement membrane in mice. Kidney Int 82:184–192PubMedCentralPubMed
67.
Kruse K, Janko C, Urbonaviciute V et al (2010) Inefficient clearance of dying cells in patients with SLE: anti-dsDNA autoantibodies, MFG-E8, HMGB-1 and other players. Apoptosis Int J Program Cell Death 15:1098–1113
68.
Lafer EM, Rauch J, Andrzejewski C Jr et al (1981) Polyspecific monoclonal lupus autoantibodies reactive with both polynucleotides and phospholipids. J Exp Med 153:897–909PubMed
69.
Lande R, Ganguly D, Facchinetti V et al (2011) Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med 3:73ra19PubMedCentralPubMed
70.
Lefkowith JB, Gilkeson GS (1996) Nephritogenic autoantibodies in lupus: current concepts and continuing controversies. Arthritis Rheum 39:894–903PubMed
71.
Lerner J, Ginsberg M, Marion TN et al (1997) Analysis of B/W-DNA 16 V(H) gene expression following DNA-peptide immunization. Lupus 6:328–329PubMed
72.
Licht R, Dieker JW, Jacobs CW et al (2004) Decreased phagocytosis of apoptotic cells in diseased SLE mice. J Autoimmun 22:139–145PubMed
73.
Liu Z, Davidson A (2012) Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nat Med 18:871–882PubMedCentralPubMed
74.
Luijten RKMC, Fritsch-Stork RD, Bijlsma JWJ et al (2013) The use of glucocorticoids in systemic lupus erythematosus. After 60 years still more an art than science. Autoimmun Rev 12:617–628PubMed
75.
Khalil M, Spatz L, Diamond B (1999) Anti-DNA antibodies. In: Lahita RG (ed) Systemic lupus erythematosus, 3rd edn. Academic, San Diego, pp 197–217
76.
Madaio MP, Hodder S, Schwartz RS et al (1984) Responsiveness of autoimmune and normal mice to nucleic acid antigens. J Immunol 132:872–876PubMed
77.
Mageed RA, Zack DJ (2002) Cross-reactivity and pathogenicity of anti-DNA autoantibodies in systemic lupus erythematosus. Lupus 11:783–786PubMed
78.
Mak A, Isenberg DA, Lau CS (2013) Global trends, potential mechanisms and early detection of organ damage in SLE. Nat Rev Rheumatol 9:301–310PubMed
79.
Meacock R, Dale N, Harrison MJ (2013) The humanistic and economic burden of systemic lupus erythematosus: a systematic review. Pharmacoeconomics 31:49–61PubMed
80.
Mjelle JE, Kalaaji M, Rekvig OP (2009) Exposure of chromatin and not high affinity for dsDNA determines the nephritogenic impact of anti-dsDNA antibodies in (NZBxNZW)F1 mice. Autoimmunity 42:104–111PubMed
81.
Mjelle JE, Rekvig OP, Fenton KA (2007) Nucleosomes possess a high affinity for glomerular laminin and collagen IV and bind nephritogenic antibodies in murine lupus-like nephritis. Ann Rheum Dis 66:1661–1668PubMedCentralPubMed
82.
Moens U, Seternes OM, Hey AW et al (1995) In vivo expression of a single viral DNA-binding protein generates systemic lupus erythematosus-related autoimmunity to double-stranded DNA and histones. Proc Natl Acad Sci U S A 92:12393–12397PubMedCentralPubMed
83.
Mortensen ES, Fenton KA, Rekvig OP (2008) Lupus nephritis: the central role of nucleosomes revealed. Am J Pathol 172:275–283PubMedCentralPubMed
84.
Mortensen ES, Rekvig OP (2009) Nephritogenic potential of anti-DNA antibodies against necrotic nucleosomes. J Am Soc Nephrol 20:696–704PubMed
85.
Mostoslavsky G, Fischel R, Yachimovich N et al (2001) Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry. Eur J Immunol 31:1221–1227PubMed
86.
Munoz LE, Janko C, Schulze C et al (2010) Autoimmunity and chronic inflammation—two clearance-related steps in the etiopathogenesis of SLE. Autoimmun Rev 10:38–42PubMed
87.
Munoz LE, Lauber K, Schiller M et al (2010) The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol 6:280–289PubMed
88.
Munoz LE, Van Bavel C, Franz S et al (2008) Apoptosis in the pathogenesis of systemic lupus erythematosus. Lupus 17:371–375PubMed
89.
Ohteki T, Hessel A, Bachmann MF et al (1999) Identification of a cross-reactive self ligand in virus-mediated autoimmunity. Eur J Immunol 29:2886–2896PubMed
90.
Oldstone MB (1987) Molecular mimicry and autoimmune disease [published erratum appears in Cell 1987 Dec 4;51(5):878]. Cell 50:819–820PubMed
91.
Petri M, Orbai AM, Alarcon GS et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677–2686PubMedCentralPubMed
92.
Pisetsky DS (2012) Antinuclear antibodies in rheumatic disease: a proposal for a function-based classification. Scand J Immunol 76:223–228PubMed
93.
Pisetsky DS (1997) Specificity and immunochemical properties of antibodies to bacterial DNA. Methods 11:55–61PubMed
94.
Pisitkun P, Deane JA, Difilippantonio MJ et al (2006) Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312:1669–1672PubMed
95.
Price JV, Tangsombatvisit S, Xu GY et al (2012) On silico peptide microarrays for high-resolution mapping of antibody epitopes and diverse protein-protein interactions. Nat Med 18:1434−1440
96.
Punaro MG (2013) The treatment of systemic lupus proliferative nephritis. Pediatr Nephrol 28:2069–2078PubMed
97.
Putterman C, Diamond B (1998) Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition. J Exp Med 188:29–38PubMedCentralPubMed
98.
Rahman A, Isenberg DA (2008) Systemic lupus erythematosus. N Engl J Med 358:929–939PubMed
99.
Ray SK, Putterman C, Diamond B (1996) Pathogenic autoantibodies are routinely generated during the response to foreign antigen: a paradigm for autoimmune disease. Proc Natl Acad Sci U S A 93:2019–2024PubMedCentralPubMed
100.
Rekvig OP, Moens U, Sundsfjord A et al (1997) Experimental expression in mice and spontaneous expression in human SLE of polyomavirus T-antigen. A molecular basis for induction of antibodies to DNA and eukaryotic transcription factors. J Clin Invest 99:2045–2054PubMedCentralPubMed
101.
Rekvig OP, Nossent JC (2003) Anti-double-stranded DNA antibodies, nucleosomes, and systemic lupus erythematosus: a time for new paradigms? Arthritis Rheum 48:300–312PubMed
102.
Ronnblom L, Alm GV, Eloranta ML (2009) Type I interferon and lupus. Curr Opin Rheumatol 21:471–477PubMed
103.
Rumore PM, Steinman CR (1990) Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone. J Clin Invest 86:69–74PubMedCentralPubMed
104.
Sabbaga J, Line SR, Potocnjak P et al (1989) A murine nephritogenic monoclonal anti-DNA autoantibody binds directly to mouse laminin, the major non-collagenous protein component of the glomerular basement membrane. Eur J Immunol 19:137–143PubMed
105.
Seredkina N, Rekvig OP (2011) Acquired loss of renal nuclease activity is restricted to DNasel and is an organ-selective feature in murine lupus nephritis. Am J Pathol 179:1120–1128PubMedCentralPubMed
106.
Seredkina N, Van der Vlag J, Berden J et al (2013) Lupus nephritis: enigmas, conflicting models and an emerging concept. Mol Med 19:161–169PubMedCentralPubMed
107.
Seredkina N, Zykova SN, Rekvig OP (2009) Progression of murine lupus nephritis is linked to acquired renal Dnase1 deficiency and not to up-regulated apoptosis. Am J Pathol 175:97–106PubMedCentralPubMed
108.
109.
Shilatifard A (2004) Transcriptional elongation control by RNA polymerase II: a new frontier. Biochim Biophys Acta 1677:79–86PubMed
110.
Shlomchik M, Mascelli M, Shan H et al (1990) Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med 171:265–292PubMed
111.
Shlomchik MJ, Marshak-Rothstein A, Wolfowicz CB et al (1987) The role of clonal selection and somatic mutation in autoimmunity. Nature 328:805–811PubMed
112.
Stollar BD (1986) Antibodies to DNA. CRC Crit Rev Biochem 20:1–36PubMed
113.
114.
Sundar K, Jacques S, Gottlieb P et al (2004) Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies. J Autoimmun 23:127–140PubMed
115.
Svejstrup JQ (2013) RNA polymerase II transcript elongation. Biochim Biophys Acta 1829:1PubMed
116.
Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMed
117.
Thiyagarajan D, Fismen S, Seredkina N et al (2012) Silencing of renal DNaseI in murine lupus nephritis imposes exposure of large chromatin fragments and activation of toll like receptors and the Clec4e. PLoS One 7:e34080PubMedCentralPubMed
118.
Tillman DM, Jou NT, Hill RJ et al (1992) Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB x NZW)F1 mice. J Exp Med 176:761–779PubMed
119.
Tsokos GC (2011) Mechanisms of disease systemic lupus erythematosus. N Engl J Med 365:2110–2121PubMed
120.
Urbonaviciute V, Furnrohr BG, Meister S et al (2008) Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 205:3007–3018PubMedCentralPubMed
121.
Utz PJ, Anderson P (1998) Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. Arthritis Rheum Us 41:1152–1160
122.
123.
Van Bavel CC, Dieker J, Muller S et al (2009) Apoptosis-associated acetylation on histone H2B is an epitope for lupus autoantibodies. Mol Immunol 47:511–516PubMed
124.
Van Bavel CC, Dieker JW, Kroeze Y et al (2011) Apoptosis-induced histone H3 methylation is targeted by autoantibodies in systemic lupus erythematosus. Ann Rheum Dis 70:201–207PubMed
125.
Van Bavel CC, Dieker JW, Tamboer WP et al (2010) Lupus-derived monoclonal autoantibodies against apoptotic chromatin recognize acetylated conformational epitopes. Mol Immunol 48:248–256PubMed
126.
Van Bavel CC, Fenton KA, Rekvig OP et al (2008) Glomerular targets of nephritogenic autoantibodies in systemic lupus erythematosus. Arthritis Rheum 58:1892–1899PubMed
127.
Van Bavel CC, Van Der Vlag J, Berden JH (2007) Glomerular binding of anti-dsDNA autoantibodies: the dispute resolved? Kidney Int 71:600–601PubMed
128.
Van Bruggen MC, Kramers C, Berden JH (1996) Autoimmunity against nucleosomes and lupus nephritis. Ann Med Interne Paris 147:485–489PubMed
129.
Van Bruggen MC, Kramers C, Hylkema MN et al (1994) Pathophysiology of lupus nephritis: the role of nucleosomes. Neth J Med 45:273–279PubMed
130.
Van Bruggen MC, Kramers C, Hylkema MN et al (1996) Significance of anti-nuclear and anti-extracellular matrix autoantibodies for albuminuria in murine lupus nephritis; a longitudinal study on plasma and glomerular eluates in MRL/l mice. Clin Exp Immunol 105:132–139PubMed
131.
Van Bruggen MC, Walgreen B, Rijke TP et al (1997) Antigen specificity of anti-nuclear antibodies complexed to nucleosomes determines glomerular basement membrane binding in vivo. Eur J Immunol 27:1564–1569PubMed
132.
Van der Vlag J, Berden JH (2011) Lupus nephritis: role of antinucleosome autoantibodies. Semin Nephrol 31:376–389PubMed
133.
Van Ghelue M, Moens U, Bendiksen S et al (2003) Autoimmunity to nucleosomes related to viral infection: a focus on hapten-carrier complex formation. J Autoimmun 20:171–182
134.
Voll RE, Roth EA, Girkontaite I et al (1997) Histone-specific Th0 and Th1 clones derived from systemic lupus erythematosus patients induce double-stranded DNA antibody production. Arthritis Rheum 40:2162–2171PubMed
135.
Weening JJ, D'agati VD, Schwartz MM et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65:521–530PubMed
136.
Westhoff CM, Whittier A, Kathol S et al (1997) DNA-binding antibodies from viable motheaten mutant mice: implications for B cell tolerance. J Immunol 159:3024–3033PubMed
137.
Widom J (1992) A relationship between the helical twist of DNA and the ordered positioning of nucleosomes in all eukaryotic cells. Proc Natl Acad Sci U S A 89:1095–1099PubMedCentralPubMed
138.
Williams RC Jr, Malone C, Blood B et al (1999) Anti-DNA and anti-nucleosome antibody affinity—a mirror image of lupus nephritis? J Rheumatol 26:331–346PubMed
139.
Winfield JB, Faiferman I, Koffler D (1977) Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis. J Clin Invest 59:90–96PubMedCentralPubMed
140.
Wu ZQ, Drayton D, Pisetsky DS (1997) Specificity and immunochemical properties of antibodies to bacterial DNA in sera of normal human subjects and patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 109:27–31PubMedCentralPubMed
141.
Xie C, Liang Z, Chang S et al (2003) Use of a novel elution regimen reveals the dominance of polyreactive antinuclear autoantibodies in lupus kidneys. Arthritis Rheum 48:2343–2352PubMed
142.
Zykova SN, Seredkina N, Benjaminsen J et al (2008) Reduced fragmentation of apoptotic chromatin is associated with nephritis in lupus-prone (NZB x NZW)F(1) mice. Arthritis Rheum 58:813–825PubMed
143.
Zykova SN, Tveita AA, Rekvig OP (2010) Renal Dnase1 enzyme activity and protein expression is selectively shut down in murine and human membranoproliferative lupus nephritis. PLoS One 5(8):e12096
Metadata
Title
The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved
Authors
Ole Petter Rekvig
Johan Van der Vlag
Publication date
01-05-2014
Publisher
Springer Berlin Heidelberg
Published in
Seminars in Immunopathology / Issue 3/2014
Print ISSN: 1863-2297
Electronic ISSN: 1863-2300
DOI
https://doi.org/10.1007/s00281-014-0428-6

Other articles of this Issue 3/2014

Seminars in Immunopathology 3/2014 Go to the issue

Editorial

Introduction: B cell-mediated autoimmune diseases

Review

Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases

Review

Plasma cells in immunopathology: concepts and therapeutic strategies

Review

Targeting B cells and autoantibodies in the therapy of autoimmune diseases

Review

B cell-mediated pathogenesis of ANCA-mediated vasculitis

Review

The pathogenic potential of autoreactive antibodies in rheumatoid arthritis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits